These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36648122)

  • 1. Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022.
    Xiong W; Peng L; Tsang TK; Cowling BJ
    Emerg Infect Dis; 2023 Feb; 29(2):453-456. PubMed ID: 36648122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau.
    Xu C; Wang J; Yu L; Sui X; Wu Q
    Front Public Health; 2022; 10():1029171. PubMed ID: 36703829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Mefsin YM; Chen D; Bond HS; Lin Y; Cheung JK; Wong JY; Ali ST; Lau EHY; Wu P; Leung GM; Cowling BJ
    Emerg Infect Dis; 2022 Sep; 28(9):1856-1858. PubMed ID: 35914518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan.
    Shao PL; Tu HC; Gong YN; Shu HY; Kirby R; Hsu LY; Yeo HY; Kuo HY; Huang YC; Lin YF; Weng HY; Wu YL; Chen CC; Chen TW; Lee KM; Huang CG; Shih SR; Chen WJ; Wu CC; Yu CJ; Tsai SF
    Emerg Infect Dis; 2023 Apr; 29(4):792-796. PubMed ID: 36918378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level.
    Zheng JX; Lv S; Tian LG; Guo ZY; Zheng PY; Chen YL; Guan SY; Wang WM; Zhang SX
    Infect Dis Poverty; 2022 Nov; 11(1):114. PubMed ID: 36434701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada.
    Cheng L; Dhiyebi HA; Varia M; Atanas K; Srikanthan N; Hayat S; Ikert H; Fuzzen M; Sing-Judge C; Badlani Y; Zeeb E; Bragg LM; Delatolla R; Giesy JP; Gilliland E; Servos MR
    Emerg Infect Dis; 2023 Aug; 29(8):1580-1588. PubMed ID: 37379513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022.
    Fowle N; Garrett B; Floyd OL; Collins J; Krasnow AD; Islas M; Holland SC; Smith MF; Lim ES; Jarrett NM; Scott SE
    Emerg Infect Dis; 2022 Jul; 28(7):1520-1522. PubMed ID: 35654405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
    Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
    Zeng K; Santhya S; Soong A; Malhotra N; Pushparajah D; Thoon KC; Yeo B; Ho ZJM; Cheng MCI
    Emerg Infect Dis; 2023 Apr; 29(4):814-817. PubMed ID: 36878009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
    Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW
    Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Epidemiology of COVID-19 in Macau S.A.R.
    Ieng SM; Cheong IH
    Front Public Health; 2020; 8():550057. PubMed ID: 33194951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan.
    Ogata T; Tanaka H
    Emerg Infect Dis; 2023 Mar; 29(3):595-598. PubMed ID: 36787734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
    Foulkes S; Monk EJM; Sparkes D; Hettiarachchi N; Milligan ID; Munro K; Taylor-Kerr A; Platt N; Howells A; Kyaw JYA; Adaji E; Gallagher E; Khawam J; Wellington E; Price L; Crossman D; Norman C; de Lacy E; Cromey L; Corrigan D; Lackenby A; Barbero P; Elegunde B; Zambon M; Chand MA; Brown CS; Islam J; Atti A; Hopkins S; Hall VJ; Cole MJ;
    Emerg Infect Dis; 2023 Jan; 29(1):184-188. PubMed ID: 36454718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Ogata T; Tanaka H
    Emerg Infect Dis; 2024 Jan; 30(1):207. PubMed ID: 38146992
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
    Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE
    Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O
    Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.